VIEWS: 15 PAGES: 3 POSTED ON: 12/4/2011
Stryker General Company Overview Stryker's surgical products include such instruments as drills, saws, rasps, even cement mixers. The company's leading product category includes artificial joints, spinal rods and screws, artificial vertebral discs, bone cement, and other orthopedic implants and supplies. Other products include endoscopy equipment, facial and hand surgery instruments, and stretchers. Stryker's Physiotherapy Associates also provides rehabilitation services at some 430 clinics in 25 states and Washington, DC. They company's Stryker Biotech division makes OP-1, a product to grow bone. The Stryker family owns about 25% of the company. Stryker operates worldwide and markets its products in more than 100 countries; sales outside of the US represent 35% of revenue. In the US and select countries, Stryker uses its own sales and marketing force. In smaller markets, though, the firm relies on distributors. Other brands of Stryker Physiotherapy Associates, Inc.- A subsidiary of Stryker Corporation, the company provides occupational, physical, and speech rehabilitation services through approximately 430 facilities across more than 25 states and the District of Columbia. Many of the firm's patients are injured workers or athletes recovering from orthopedic injuries or neurological conditions; it also offers wound care for diabetic patients. Stryker UK Limited- Founded in 1984, the company is a part of the worldwide orthopedic medical device firm, Stryker Corporation. Stryker UK offers joint replacements, spinal implants, orthobiologics, powered surgical instruments, surgical navigation systems, and endoscopic products. The company also sells emergency medical equipment and distributes medical devices from other firms, such as pain management devices from US firm McKinley Medical (a subsidiary of The Broe Companies). Top Competitors DePuy- A subsidiary of Johnson & Johnson, DePuy is a leading supplier of orthopedic products, competing against fellow industry bigwigs Biomet and Zimmer, a spinoff of Bristol-Myers Squibb. DePuy's products include hip replacements; knee, shoulder, and spinal implants; fixative products for bone fractures; and operating room products. The company's products are used primarily by orthopedic specialists and neurosurgeons to treat patients with musculoskeletal defects resulting from diseases, deformities, trauma, or sports accidents. Smith & Nephew- Focusing on orthopedics, wound care, and endoscopy, the firm makes products to repair joints, skin, soft tissue, and bone. Smith & Nephew Orthopaedics makes hip, knee, and shoulder replacements, in addition to nailing systems used to repair broken bones. Smith & Nephew also makes arthroscopes, blades, digital cameras, and other products for endoscopic surgery. Zimmer- The company designs and markets orthopedic products, including reconstructive implants and fracture management devices. Reconstructive implants -- which restore function in knees, hips, shoulders, elbows, and teeth that have been exposed to trauma or disease -- account for some three-quarters of sales. Products include the NexGen knee implant series and the VerSys system for hips. Zimmer also sells surgical supplies, such as tourniquets and blood management systems. The company operates facilities in more than 20 countries and sells its products worldwide. In the News 12/18/2005, NewsRxDrugs, Digital x-ray company systems announces partnership with Stryker Fujifilm Medical Systems USA, Inc., a digital x-ray company, and Stryker Imaging, a division of Stryker Corp. and a worldwide manufacturer and supplier of orthopedic medical devices, have announced a sales agreement. With this new partnership Stryker will exclusively distribute Fuji's computed radiography (CR) solutions in the orthopedic market and is expected to significantly increase the adoption of digital x-ray in this practice area. 12/15/2005, CHEMICAL BUSINESS NEWSBASE - PRESS RELEASE, Stryker announces 11 cts/share year-end cash dividend, a 22% increase Stryker Corp announced that the Board of Directors has declared a year-end cash dividend of 11 cts/share, an increase of 22% over the 9 cts dividend declared in Dec 2004. The dividend is payable 31 Jan 2006 to shareholders of record at the close of business on 30 Dec 2005. Stryker Corp is one of the world's leading medical device companies with the most broadly-based range of products in orthopaedics and a significant presence in other medical specialties.
Pages to are hidden for
"stryker (DOC)"Please download to view full document